# Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis

> **NCT00622687** · PHASE2 · TERMINATED · sponsor: **Charite University, Berlin, Germany** · enrollment: 50 (actual)

## Conditions studied

- Systemic Sclerosis

## Interventions

- **DRUG:** iloprost
- **DRUG:** iloprost low dose
- **DRUG:** iloprost therapy up to 2 ng/kg x min

## Key facts

- **NCT ID:** NCT00622687
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1997-09
- **Primary completion:** 2003-12
- **Final completion:** 2007-12
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** sufficient number to reach the primary endpoint and as planned
- **Last updated:** 2008-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00622687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00622687, "Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00622687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*